Stock Events

Stock Events

Atrium Therapeutics (RNA) Q2 2025 Earnings

8MayConfirmed

Q3 2024

Q4 2024

Q1 2025

Q2 2025

-0.9

-0.82

-0.73

-0.65

Details

Expected EPS

-0.875495

Actual EPS

-0.9

Surprise EPS

-0.02

Surprise Percent

+2.8%

Description

Atrium Therapeutics (RNA) has reported earnings of -0.9 per share for Q2 2025.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.